Hiroki Nishiwaki
Overview
Explore the profile of Hiroki Nishiwaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishimoto M, Hasegawa T, Murashima M, Noma H, Nishiwaki H, Yamada S, et al.
Clin J Am Soc Nephrol
. 2025 Mar;
PMID: 40085178
Background: It is necessary to update the evidence of each phosphate-lowering agent on dialysis patients. Methods: From the CENTRAL, MEDLINE, EMBASE, and ClinicalTrial.gov databases, randomized controlled trials (RCTs) using oral...
2.
Nishiwaki H, Missikpode C, Ricardo A, Yang W, Anderson A, Lash J, et al.
Am J Kidney Dis
. 2025 Mar;
PMID: 40054592
Rationale & Objective: Previous reports have identified increased estimated glomerular filtration rate (eGFR) variability, measured during a single ascertainment window, as a risk factor for cardiovascular disease and all-cause mortality....
3.
Kosugi T, Hasegawa T, Imaizumi T, Nishiwaki H, Honda H, Ito Y, et al.
Clin Exp Nephrol
. 2025 Feb;
PMID: 39932639
Background: The optimal hemoglobin (Hb) range in patients undergoing hemodialysis remains controversial. We aimed to investigate the association between Hb levels and mortality in patients undergoing hemodialysis and explore the...
4.
Nishiwaki H, Imaizumi T, Hasegawa T, Kosugi T, Maruyama Y, Tsuruya K, et al.
Am J Nephrol
. 2025 Feb;
:1-11.
PMID: 39894014
Introduction: We evaluated the association between iron-related biomarkers - key indicators of iron metabolism and inflammation, and crucial in the management of anemia in patients undergoing hemodialysis - and all-cause...
5.
Kosugi T, Hasegawa T, Imaizumi T, Nishiwaki H, Honda H, Ito Y, et al.
J Ren Nutr
. 2025 Jan;
PMID: 39864472
Objectives: Anemia is a common complication associated with adverse outcomes in older patients undergoing hemodialysis (HD). They also tend to experience malnutrition, which can affect the course of anemia. We...
6.
Imaizumi T, Hasegawa T, Kosugi T, Nishiwaki H, Abe M, Hanafusa N, et al.
Sci Rep
. 2025 Jan;
15(1):2689.
PMID: 39838061
Preservation of residual kidney function (RKF) is important in patients undergoing peritoneal dialysis (PD). We aimed to examine the association between anemia management and residual urine output using data from...
7.
Abe Y, Nishiwaki H, Suzuki T, Noma H, Watanabe Y, Ota E, et al.
BMJ Open
. 2025 Jan;
14(12):e084088.
PMID: 39806632
Introduction: Coenzyme Q10 (CoQ10) is a fat-soluble vitamin-like quinone. The plasma levels of CoQ10 are reduced in patients with chronic kidney disease (CKD). CoQ10 supplementation can improve mitochondrial function and...
8.
Takami R, Nagayama Y, Nishiwaki H, Ueno T, Iwasaki S, Yoshimura A, et al.
Case Rep Nephrol Dial
. 2024 Oct;
14(1):158-163.
PMID: 39474254
Introduction: Malakoplakia is a rare and chronic granulomatous disease that is pathologically characterized by the presence of Michaelis-Gutmann bodies and large macrophage clusters. Malakoplakia of the renal parenchyma is especially...
9.
Nishiwaki H, Abe Y, Suzuki T, Hasegawa T, Levack W, Noma H, et al.
Cochrane Database Syst Rev
. 2024 Sep;
9:CD014820.
PMID: 39301879
Background: Acute kidney injury (AKI) is characterised by a rapid decline in kidney function and is caused by a variety of clinical conditions. The incidence of AKI in hospitalised adults...
10.
Tsuji K, Sasai H, Kiyohara K, Nakata Y, Nishiwaki H, Ohta T, et al.
Jpn J Clin Oncol
. 2024 Sep;
55(1):12-20.
PMID: 39297634
Objective: This research aimed to establish the inaugural evidence-based cancer survivorship guidelines for Japan, with a particular focus on exercise and physical activity, in order to enhance health outcomes for...